3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
13
Oropharyngeal Neoplasms
12
Lung Neoplasms
9
Laryngeal Neoplasms
8
Carcinoma
8
Mouth Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Hypopharyngeal Neoplasms
6
Uterine Cervical Neoplasms
5
Nasopharyngeal Carcinoma
5
Mesothelioma, Malignant
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Triple Negative Breast Neoplasms
3
Salivary Gland Neoplasms
3
Ovarian Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Testicular Neoplasms
2
Seminoma
2
Paranasal Sinus Neoplasms
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Fallopian Tube Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Interventions
tremelimumab
2
pembrolizumab
2
Nivolumab
2
Carboplatin
2
poly ICLC
1
osimertinib
1
lenvatinib
1
durvalumab
1
cemiplimab
1
balstilimab
1
Vascular Endothelial Growth Factor A
1
Peptides
1
Pemetrexed
1
Paclitaxel
1
Ipilimumab
1
Docetaxel
1
Blood Specimen Collection
1
Antibodies, Bispecific
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Insulin-Dependent, 12
×
Platinum
×
90 days
×
Clear all
No trials found.